| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Cleveland-Cliffs shares gained 1.4% to close at $12.43 on Friday while Bristol-Myers Squibb shares gained 1% to close at $46.07.
																	Goldman Sachs analyst Mike Harris maintains Cleveland-Cliffs (NYSE:CLF) with a Buy and raises the price target from $14.5 to...
																	
																	Shares of Cleveland-Cliffs are trading lower Thursday after the company announced the pricing of a public offering of 75 millio...
																	
																	Cleveland-Cliffs Inc. (NYSE: CLF) is pleased to announce that POSCO, Korea's largest steelmaker and the world's third l...
																	Cleveland-Cliffs priced its underwritten public offering (the "Offering") of 75,000,000 common shares, par value $0.125...
																	
																	-SEC Filing